Theralase Technologies Inc. V.TLT

Theralase Researchers Receive Government Grant 2018 4.5mil

[floatinketucky]

Govenment supporting the science is already established. The Canadian Government knows where to invest to capatalize from this distruptive tech.  They will recieve much more back in taxes... very soon...   JMO

June 28, 2018  Toronto, Ontario - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical-stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations used to safely and effectively destroy cancer is pleased to announce that Theralase researchers; specifically: University Health Network (“UHN”) and the University of Toronto (“UT”) have received an Ontario Research Fund – Research Excellence (“ORF-RE”) grant with a primary mandate of advancing personalized Anti-Cancer Photo Dynamic Therapy (“PDT”) for each individual cancer patient to safely and effectively destroy their particular cancer, while maintaining the highest possible quality of life for them.

UHN and UT were successfully awarded an ORF-RE grant valued at $CAN 4.5 million, with financial and technical support provided by world-class industrial and institutional partners, such as: IBM Canada, Altera (Intel), Theralase and Companion Healthcare Corporation (“CHC”), further supported with funding from the Ontario government’s Ministry of Research and Innovation and Science.

The grant is in support of the project entitled, “Personalized Photodynamic Cancer Therapy Using Robust and Validated Simulation Tools”,
Theralae Researchers Receive Gov Grant 2018

 

[floatinketucky]

 University Health Network (“UHN”) and the University of Toronto (“UT”) have received an Ontario Research Fund – Research Excellence (“ORF-RE”) grant with a primary mandate of advancing personalized Anti-Cancer Photo Dynamic Therapy (“PDT”) for each individual cancer patient to safely and effectively destroy their particular cancer, while maintaining the highest possible quality of life for

[floatinketucky]

Don't ya kinda thnk the patients for this funding are getting treated currently??? And how many could you treat for 4.5 million??  Enough patients for the study completion may be a good starting point for consideration. Yes...   DD DD DD

[CAinPlap]

Not entirely certain this funding was earmarked for Theralase. UHN received the funds No mention they were using for our trial(s). Not sure what other PDT research companies they are or could be working with.

[floatinketucky]

UHN and UT researchers will specifically focus on developing algorithms focused on optimizing and predicting patient response to PDT when treated for a range of cancers, including: bladder, brain, lung, esophagus, head and neck and female reproductive organs. The safety and efficacy of the PDT will be tested and validated initially in animals and with that knowledge, the optimized procedures will

[floatinketucky]

They will get data points and the chase will be on. Buy now or chase later. The money is a much lesser an issue than the tech development. Look to the actions and money supplied by the Canadian Government. They understand the data and it's market value. That's why they are putting up millions for PDT. Thats why the analysis said that in one of his posts. They are already crossing the

[lesflics]

I'm putting floatinketucky on ignore. It's nothing personal. His posts may be helpful to newbies but they're a nuisance for longs who are waiting anxiously for real news. I'm not interested in news from 2018.

[Legit62]

Im a newbie and would agree. Does anyone have access to whether any inside share purchases recently? that would be good info since insiders cant buy if they have news that has not been released publicly. and obviously if they felt this stock was about to explode, more shares would be purchased? 

[Lesalpes29]

Last transaction.. december 16th. Nothing since.